New sizes of advanced articulating microcatheter enhance a market-leading portfolio of vascular access products SOUTH JORDAN, Utah, March 20, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the expansion of its SwiftNINJA Steerable Microcatheter product line. New sizes include a low-profile

New sizes of advanced articulating microcatheter enhance a market-leading portfolio of vascular access products New sizes of advanced articulating microcatheter enhance a market-leading portfolio of vascular access products

Neil Peterson , Chief Operating Officer at Merit Medical Systems (NASDAQ: MMSI ), reported a large acquisition of company stock options on March 2, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Peterson, Chief Operating Officer at Merit Medical Systems, a company in the Health Care sector, was just awarded stock options worth 13,576 shares of MMSI. The options give Peterson the right to buy the company''s stock at $70.58 per share. Merit Medical Systems shares are trading down 0.11% at $69.8 at the time of this writing on Friday morning. Since the current price is $69.8, this makes … Full story available on Benzinga.com

Joseph Wright , Chief Commercial Officer at Merit Medical Systems (NASDAQ: MMSI ), reported a large acquisition of company stock options on March 2, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Wright, Chief Commercial Officer at Merit Medical Systems, a company in the Health Care sector, was just awarded stock options worth 13,576 shares of MMSI. The options give Wright the right to buy the company''s stock at $70.58 per share. Merit Medical Systems shares are trading down 0.11% at $69.8 at the time of this writing on Friday morning. Since the current price is $69.8, this makes … Full story available on Benzinga.com

Brian G Lloyd , Chief Legal Officer at Merit Medical Systems (NASDAQ: MMSI ), reported a large acquisition of company stock options on March 2, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Lloyd, Chief Legal Officer at Merit Medical Systems, a company in the Health Care sector, was just awarded stock options worth 13,576 shares of MMSI. The options give Lloyd the right to buy the company''s stock at $70.58 per share. Merit Medical Systems shares are trading down 0.11% at $69.8 at the time of this writing on Friday morning. Since the current price is $69.8, this … Full story available on Benzinga.com

I think Merit Medical has further upside vs. consensus at the top and bottom lines. Click here to read my analysis detailing why I think MMSI stock is a buy.

Merit Medical delivered a modestly better than expected Q4, with a little upside on revenue and a modest beat at the operating income line. See why MMSI is a Buy.

Merit Medical Systems, Inc. (NASDAQ:NASDAQ:MMSI) Q4 2022 Earnings Conference Call February 22, 2023 5:00 PM ETCompany ParticipantsFred Lampropoulos - Founder, Chairman & Chief Executive…

The following slide deck was published by Merit Medical Systems, Inc.

SOUTH JORDAN, Utah (AP) — SOUTH JORDAN, Utah (AP) — Merit Medical Systems Inc. (MMSI) on Wednesday reported fourth-quarter profit…

Merit Medical Systems press release (MMSI): Q4 Non-GAAP EPS of $0.79 beats by $0.12.Revenue of $293.4M (+5.4% Y/Y) beats by $3.26M.FY23 Guidance: Net Sales - $1.194B - $1.210B vs…

* Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross profit and margin; and free cash flow are non-GAAP financial measures. A reconciliation of these financial measures to their most directly comparable GAAP financial measures is included under the heading “Non-GAAP Financial Measures” below.

Next-generation system helps improve surgical precision to enhance patient care in breast and other soft tissue cancer treatment SOUTH JORDAN, Utah, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today the FDA has granted Breakthrough Device Designation for the SCOUT MD Surgical Guidance

Next-generation system helps improve surgical precision to enhance patient care in breast and other soft tissue cancer treatment Next-generation system helps improve surgical precision to enhance patient care in breast and other soft tissue cancer treatment

NEW YORK, Feb. 10, 2023 /PRNewswire/ -- Major players in the interventional neurology devices and equipment market are Medtronic, Stryker, Terumo Corporation, Penumbra, COVIDien, Abbott, Merit Medical Systems, Johnson & Johnson Services Inc, W.L. Read the full report:…

SOUTH JORDAN, Utah, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the fourth quarter and year ended December 31, 2022, and issue fiscal year 2023 guidance after the close of the stock market on Wednesday, February 22, 2023.